Literature DB >> 20337969

Immunologic analysis and serum heavy metal levels in exacerbated Tourette syndrome.

Meng-Ying Hsieh1, Wen-I Lee, Kuang-Lin Lin, Po-Chen Hung, Ming-Liang Chou, Ming-Yu Chang, Jing-Long Huang, Huei-Shyong Wang.   

Abstract

Tourette syndrome (TS) is a childhood-onset and relapsing disorder characterized by involuntary simple or complex tics and high co-morbidity with behavioral anomalies. Its pathophysiologic mechanisms remain unclarified. We investigated immunologic alternations and serum heavy metal levels in patients with TS to elucidate the unclarified mechanisms. Based on the Yale Global Tic Severity Scale, fifteen TS subjects (four females) aged 8-34 (mean: 15.4 +/- 6.7) in exacerbation with mean severity score 40.3 +/- 14.6 were enrolled in this study. The immunoglobulin levels were normal except for higher immunoglobulin E levels (in 10 patients) with atopy. In exacerbation, there were reverse CD4/CD8 (in two), higher percentages of natural killer cells (in five) and memory T cells (in eight), diminished lymphocyte activation CD69 marker (in three) and impaired NK cytotoxicity (in six) that showed a trend of lower inhibitory CD94 (NKG2A), activating NKp46, and perforin expression compared to those of patients with stable TS and healthy controls, but similar granzyme expression. Serum ASLO, mycoplasma antibody and the levels of heavy metals were not significantly different. All aforementioned immune alterations returned to the normal ranges except for the consistently higher memory T cells. Our study demonstrated that, in some patients with TS, consistently higher memory T cells and lower cytotoxicity in exacerbation status reflect immune alterations and underscore the potential for immunomodulation or immunosuppressive treatment.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20337969     DOI: 10.1111/j.1399-3038.2010.01009.x

Source DB:  PubMed          Journal:  Pediatr Allergy Immunol        ISSN: 0905-6157            Impact factor:   6.377


  2 in total

1.  Involvement of immunologic and biochemical mechanisms in the pathogenesis of Tourette's syndrome.

Authors:  Yuval Eliahu Landau; Tamar Steinberg; Brian Richmand; James Frederick Leckman; Alan Apter
Journal:  J Neural Transm (Vienna)       Date:  2011-12-03       Impact factor: 3.575

Review 2.  Immune-mediated animal models of Tourette syndrome.

Authors:  Mady Hornig; W Ian Lipkin
Journal:  Neurosci Biobehav Rev       Date:  2013-01-10       Impact factor: 8.989

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.